从药品集中招标采购透视医疗费用居高不下  

Viewing the High Medical Expenses from the Perspective of Pharmaceuticals Purchase by Public Bidding

作　　者：崔岚[1] 杨达宽[1] 

机构地区：[1]昆明医学院附属第二医院,昆明市650101

出　　处：《中国药房》2006年第11期868-870,共3页China Pharmacy

摘　　要：目的:探讨降低医疗费用的相关措施。方法:对比药品集中招标采购工作开展前、后某医院药品收入的相关数据,并分析医院药品费用居高不下的原因。结果:医院从药品收入中获取的利润呈逐年下降趋势,但医院药品收入又呈逐年增长趋势。其与多方面原因有关。结论:药品集中招标采购仍未从根本上解决医疗费用居高不下的问题。OBJECTIVE： To discuss the related measures for the reduction of medical expenses. METHODS： The related data concerning hospital drug revenues before and after the operation of ＇ pharmaceuticals purchase by public bidding＇ were compared,and reasons for the high undescended hospital drug expenses were analyzed .RESULTS：Although the drug revenues kept increasing year by year, yet the profits gained by hospitals from which decreased year by year, which may resulted from many factors.CONCLUSIONS： The operation of the ＇ pharmaceuticals purchase by public bidding＇ failed to bring down the high medical expenses.

关 键 词：医疗机构 药品集中招标采购 医疗费用 对策 

分 类 号：F714[经济管理—产业经济] R95[医药卫生—药学]